Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v6-FR
Language English French
Date Updated 2020-08-21 2020-07-23
Drug Identification Number 02432854 02432854
Brand name DUAVIVE DUAVIVE
Common or Proper name Duavive Duavive
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients CONJUGATED ESTROGENS BAZEDOXIFENE CONJUGATED ESTROGENS BAZEDOXIFENE
Strength(s) 0.45MG 20MG 0.45MG 20MG
Dosage form(s) TABLET (IMMEDIATE AND EXTENDED RELEASE) TABLET (IMMEDIATE AND EXTENDED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 28's blister 28's blister
ATC code G03CC G03CC
ATC description ESTROGENS ESTROGENS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-05-11 2020-05-11
Estimated end date 2020-12-11 2020-10-02
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments